Page 56 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 56

44    Assurance of sterility for sensitive combination products and materials


          is typically implanted or injected, the patient risk profile is similar between
          the various microbial sources. This makes the controls for all levels of con-
          tamination a high concern.
             Based on the standard definition of process risk where risk is the rela-
          tionship of severity of a hazard (in this case loss of sterility), probability of
          the hazard occurring, and ability to detect the hazard, the severity would be
          high, occurrence inconclusive, and detection relatively poor. Therefore, the
          overall risk is high.
             Because the current detection technology and the correlation between
          what can be observed, and the desired outcome is not strong, significantly
          reducing this risk through detection is not likely. The best way to control an
          aseptic process failure and reduce the aseptic processing risk is by reducing
          the likelihood of occurrence through sound risk and science-based process
          control strategies and design.


          4.4  Aseptic process design
          Proper design and planning of the aseptic process are essential to ensuring a
          compliant and effective sterile combination product manufacturing process.
          One of the first steps is to understand the objective of the process and its
          relationship to product quality and output. The objective of the aseptic pro-
          cess is preventing contamination during the manufacturing of the product.


          4.5  Sterility by design

          To provide effective process control, it is essential to identify all process vari-
          ables that impact the product output. Attaining primary confidence in the
          process should happen during the design of the process, rather than during
          final process qualification testing or continued process verification. It is this
          confidence that enables the company to commit to the process design [8].


          4.6  Line of sight [9]

          One method of identifying critical process parameters early in the develop-
          ment stages is to use the line of sight (LOS) approach, as noted in Fig. 4.1.
          In a LOS approach, the objective of the aseptic process design is kept in
          sight. All actions are focused on achieving this objective. The objective is
          the establishment and maintenance of a critical quality attribute (CQA), in
          this case, product sterility. All actions taken in the design should be able to
   51   52   53   54   55   56   57   58   59   60   61